These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 27045771)
1. Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties. Geng SB; Wittekind M; Vigil A; Tessier PM Mol Pharm; 2016 May; 13(5):1636-45. PubMed ID: 27045771 [TBL] [Abstract][Full Text] [Related]
2. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies. Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y MAbs; 2015; 7(3):553-61. PubMed ID: 25790175 [TBL] [Abstract][Full Text] [Related]
3. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability. Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550 [TBL] [Abstract][Full Text] [Related]
4. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy. Wu J; Schultz JS; Weldon CL; Sule SV; Chai Q; Geng SB; Dickinson CD; Tessier PM Protein Eng Des Sel; 2015 Oct; 28(10):403-14. PubMed ID: 26363633 [TBL] [Abstract][Full Text] [Related]
5. Application of Affinity-Capture Self-Interaction Nanoparticle Spectroscopy in Predicting Protein Stability, Especially for Co-Formulated Antibodies. Zhou M; Yan Z; Li H; Liu X; Sun P Pharm Res; 2021 Apr; 38(4):721-732. PubMed ID: 33754257 [TBL] [Abstract][Full Text] [Related]
6. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy. Liu Y; Caffry I; Wu J; Geng SB; Jain T; Sun T; Reid F; Cao Y; Estep P; Yu Y; Vásquez M; Tessier PM; Xu Y MAbs; 2014; 6(2):483-92. PubMed ID: 24492294 [TBL] [Abstract][Full Text] [Related]
7. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates. Sule SV; Dickinson CD; Lu J; Chow CK; Tessier PM Mol Pharm; 2013 Apr; 10(4):1322-31. PubMed ID: 23383873 [TBL] [Abstract][Full Text] [Related]
8. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties. Starr CG; Makowski EK; Wu L; Berg B; Kingsbury JS; Gokarn YR; Tessier PM Mol Pharm; 2021 Jul; 18(7):2744-2753. PubMed ID: 34105965 [TBL] [Abstract][Full Text] [Related]
10. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools. Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473 [TBL] [Abstract][Full Text] [Related]
11. An accelerated surface-mediated stress assay of antibody instability for developability studies. Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P MAbs; 2020; 12(1):1815995. PubMed ID: 32954930 [TBL] [Abstract][Full Text] [Related]
12. High-throughput assay for measuring monoclonal antibody self-association and aggregation in serum. Li X; Geng SB; Chiu ML; Saro D; Tessier PM Bioconjug Chem; 2015 Mar; 26(3):520-8. PubMed ID: 25714504 [TBL] [Abstract][Full Text] [Related]
13. Emerging methods for identifying monoclonal antibodies with low propensity to self-associate during the early discovery process. Tessier PM; Wu J; Dickinson CD Expert Opin Drug Deliv; 2014 Apr; 11(4):461-5. PubMed ID: 24444112 [TBL] [Abstract][Full Text] [Related]
14. Facile Preparation of Stable Antibody-Gold Conjugates and Application to Affinity-Capture Self-Interaction Nanoparticle Spectroscopy. Geng SB; Wu J; Alam ME; Schultz JS; Dickinson CD; Seminer CR; Tessier PM Bioconjug Chem; 2016 Oct; 27(10):2287-2300. PubMed ID: 27494306 [TBL] [Abstract][Full Text] [Related]
15. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions. Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ MAbs; 2015; 7(1):212-30. PubMed ID: 25559441 [TBL] [Abstract][Full Text] [Related]
16. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice. Kelly RL; Sun T; Jain T; Caffry I; Yu Y; Cao Y; Lynaugh H; Brown M; Vásquez M; Wittrup KD; Xu Y MAbs; 2015; 7(4):770-7. PubMed ID: 26047159 [TBL] [Abstract][Full Text] [Related]
17. Improving monoclonal antibody selection and engineering using measurements of colloidal protein interactions. Geng SB; Cheung JK; Narasimhan C; Shameem M; Tessier PM J Pharm Sci; 2014 Nov; 103(11):3356-3363. PubMed ID: 25209466 [TBL] [Abstract][Full Text] [Related]
18. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations. Buck PM; Chaudhri A; Kumar S; Singh SK Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in silico assessment of the developability of a designed monoclonal antibody library. Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N MAbs; 2019; 11(2):388-400. PubMed ID: 30523762 [TBL] [Abstract][Full Text] [Related]
20. Biospecific protein immobilization for rapid analysis of weak protein interactions using self-interaction nanoparticle spectroscopy. Bengali AN; Tessier PM Biotechnol Bioeng; 2009 Oct; 104(2):240-50. PubMed ID: 19489026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]